dc.contributor.author | Merchant, S | |
dc.contributor.author | Allott, L | |
dc.contributor.author | Carroll, L | |
dc.contributor.author | Tittrea, V | |
dc.contributor.author | Kealey, S | |
dc.contributor.author | Witney, TH | |
dc.contributor.author | Miller, PW | |
dc.contributor.author | Smith, G | |
dc.contributor.author | Aboagye, EO | |
dc.date.accessioned | 2016-08-17T11:19:24Z | |
dc.date.issued | 2016-01-01 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000378755200108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier.citation | RSC ADVANCES, 2016, 6 (62), pp. S7569 - S7579 (11) | |
dc.identifier.issn | 2046-2069 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/55 | |
dc.identifier.doi | 10.1039/c6ra07404a | |
dc.description.abstract | <p>This work features the synthesis and biological evaluation of a novel fluorinated derivative of tanaproget and a carbon-11 labelled analogue, a high affinity non-steroidal PR ligand, as a possible candidate for imaging PR expression<italic>in vivo</italic>.</p> | |
dc.format.extent | S7569 - S7579 (11) | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ROYAL SOC CHEMISTRY | |
dc.subject | Science & Technology | |
dc.subject | Physical Sciences | |
dc.subject | Chemistry, Multidisciplinary | |
dc.subject | Chemistry | |
dc.subject | BREAST-CANCER | |
dc.subject | ENDOCRINE THERAPY | |
dc.subject | ESTROGEN | |
dc.subject | PET | |
dc.subject | CARCINOMA | |
dc.subject | AFFINITY | |
dc.subject | ANALOGS | |
dc.subject | LIGAND | |
dc.title | Synthesis and pre-clinical evaluation of a [F-18] fluoromethyl-tanaproget derivative for imaging of progesterone receptor expression | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1039/c6ra07404a | |
rioxxterms.licenseref.startdate | 2016-01-01 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | RSC ADVANCES | |
pubs.issue | 62 | |
pubs.notes | No embargo | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/PET Radiochemistry | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/PET Radiochemistry | |
pubs.publication-status | Published | |
pubs.volume | 6 | |
pubs.embargo.terms | No embargo | |
icr.researchteam | PET Radiochemistry | |
dc.contributor.icrauthor | Smith, Graham | |